Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jtho.2020.04.015 http://scihub22266oqcxt.onion/10.1016/j.jtho.2020.04.015 32353597!7185017!32353597     free     free     free  :  Publisher  :   free Nephropedia Template TP {{tp|p=32353597|t=2020. Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy |pdf=|usr=}} gab.com Text Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy JO: J Thorac Oncol http://www.kidney.de/pget.php?&tw=1&pmid=32353597 #FOAvip The coronavirus disease 2019 outbreak is evolving rapidly worldwide. The lungs are the target of the primary infection and patients with lung cancer seem to have a poor prognosis. To our knowledge, this is the first reported investigation of a possible role of interleukin-17 target therapy in patients with lung cancer and concomitant severe acute respiratory syndrome-coronavirus-2 infection. Twit Text FOAVip Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy 🦆🦆J Thorac Oncol http://www.kidney.de/pget.php?&tw=1&pmid=32353597 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32353597 #FOAvip English Wikipedia <ref>{{Cite pmid|32353597}}</ref> Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy #MMPMID32353597 Cafarotti S J Thorac Oncol 2020[Jul]; 15 (7): e101-e103 PMID32353597show ga The coronavirus disease 2019 outbreak is evolving rapidly worldwide. The lungs are the target of the primary infection and patients with lung cancer seem to have a poor prognosis. To our knowledge, this is the first reported investigation of a possible role of interleukin-17 target therapy in patients with lung cancer and concomitant severe acute respiratory syndrome-coronavirus-2 infection. |*Betacoronavirus/drug effects/physiology[MESH] |*Coronavirus Infections/drug therapy/immunology[MESH] |*Interleukin-17/antagonists & inhibitors/immunology[MESH] |*Lung Neoplasms/drug therapy/immunology[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/drug therapy/immunology[MESH] |*Respiratory Distress Syndrome/drug therapy/immunology[MESH] |COVID-19[MESH] |Chemokines, CXC/metabolism[MESH] |Drug Discovery[MESH] |Humans[MESH] |Inflammation/immunology[MESH] |Molecular Targeted Therapy/methods[MESH] |SARS-CoV-2[MESH] |Th17 Cells/immunology[MESH] |Up-Regulation/drug effects[MESH]Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Patients(epmc).pdf DeepDyve Pubget Overpricing